• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by HealthEquity Inc. (Amendment)

    2/9/24 9:16:06 AM ET
    $HQY
    Business Services
    Consumer Discretionary
    Get the next $HQY alert in real time by email
    SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.1 HEALTHEQUITY INC COMMON STOCK Cusip #42226A107 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #42226A107 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 5,193,892 Item 6: 0 Item 7: 5,213,014 Item 8: 0 Item 9: 5,213,014 Item 11: 6.075% Item 12: HC Cusip #42226A107 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 5,213,014 Item 8: 0 Item 9: 5,213,014 Item 11: 6.075% Item 12: IN Item 1(a). Name of Issuer: HEALTHEQUITY INC Item 1(b). Address of Issuer's Principal Executive Offices: 15 WEST SCENIC POINTE DRIVE, SUITE 100 DRAPER, UT 84020 USA Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: COMMON STOCK Item 2(e). CUSIP Number: 42226A107 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 5,213,014 (b) Percent of Class: 6.075% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 5,213,014 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of HEALTHEQUITY INC. No one other person's interest in the COMMON STOCK of HEALTHEQUITY INC is more than five percent of the total outstanding COMMON STOCK. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 8, 2024 Date /s/ Stephanie J. Brown Signature Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification FIAM LLC IA Fidelity Management & Research Company LLC * IA Strategic Advisers LLC IA * Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on February 8, 2024, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the COMMON STOCK of HEALTHEQUITY INC at December 29, 2023. FMR LLC By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
    Get the next $HQY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HQY

    DatePrice TargetRatingAnalyst
    3/25/2025$120.00 → $115.00Outperform → Strong Buy
    Raymond James
    12/4/2024$126.00Outperform
    Mizuho
    11/15/2024$108.00Neutral
    Goldman
    4/4/2024$101.00Mkt Outperform
    JMP Securities
    4/2/2024$86.00 → $108.00Overweight
    JP Morgan
    1/3/2024$84.00Overweight
    Barclays
    9/21/2023$79.00 → $87.00Neutral → Outperform
    Robert W. Baird
    10/21/2022$64.00 → $77.00Sell → Neutral
    Goldman
    More analyst ratings

    $HQY
    Leadership Updates

    Live Leadership Updates

    See more
    • HealthEquity Reports Year-End Sales Metrics

      DRAPER, Utah, Feb. 18, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced its HSAs, HSA Assets and Total Accounts as of its fiscal year ended January 31, 2025. The Company also affirmed its guidance for fiscal 2025 and 2026, provided an updated HSA cash repricing schedule, and announced upcoming events and presentations. The total number of HSAs as of January 31, 2025 was 9.9 million, an increase of 14%, from 8.7 million as of January 31, 2024. The Company closed its fiscal year 2025 with 17.0 million Total Accounts, an increase of 9%, from 15.7 million as of January 31,

      2/18/25 4:01:00 PM ET
      $HQY
      Business Services
      Consumer Discretionary
    • HealthEquity Announces Record Year-End HSA Sales Outlook, Presentation at J.P. Morgan Healthcare Conference

      DRAPER, Utah, Jan. 13, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced estimates of HSAs, HSA Assets and Total Accounts for its fiscal year ending January 31, 2025, reflecting a strong sales year with record New HSAs from Sales and strong custodial HSA Asset growth. Estimated HSAs to be approximately 9.8 million by January 31, 2025, up from 8.7 million a year earlier.Estimated HSA Assets to be approximately $31 billion, up from $25.2 billion at the end of fiscal year 2024, with approximately $17 billion of HSA Cash. Invested balances included in the estimated assets a

      1/13/25 9:01:00 AM ET
      $HQY
      Business Services
      Consumer Discretionary
    • HSA Week 2024 Offers Free Resources and Personalized Healthcare Savings Paths

      DRAPER, Utah, Aug. 21, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity"), the leader in health savings accounts (HSAs) and consumer-directed benefits administration, will kick off the second annual HSA WeekTM on August 26. The weeklong event will include a variety of resources to educate workers and companies about HSAs and their potential to improve healthcare savings and financial stability. According to a recent HealthEquity research study, roughly 40% of employees lack confidence in their health plan decisions and more than half wonder at times if they have chosen the right plan for their needs. The good news is that education can help. The study also found th

      8/21/24 8:30:00 AM ET
      $HQY
      Business Services
      Consumer Discretionary

    $HQY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • USA Today Names HealthEquity to its Top 25 Workplaces

      DRAPER, Utah, April 29, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity"), the nation's largest health savings account (HSA) administrator, today announced it has been named a USA Today Top Workplace for 2025, ranking 23rd nationwide for companies with more than 2,500 employees. This is HealthEquity's fourth consecutive year on the coveted list, and it is the only company from the healthcare benefits industry to be ranked in the Top 25. "This award is a testament to our incredible teammates who show up every day—wherever they are—with purpose, passion, and care for one another. They've proven that a thriving culture isn't bound by office walls. It's built through t

      4/29/25 9:00:00 AM ET
      $HQY
      Business Services
      Consumer Discretionary
    • HealthEquity's Expedited Claims Technology Wins Artificial Intelligence Excellence Awards

      DRAPER, Utah, April 15, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity"), the nation's largest Health Savings Account (HSA) administrator, has been recognized by the Business Intelligence Group for its Expedited Claims AI system at the 2025 Artificial Intelligence Excellence Awards. The award honors outstanding organizations, products, and individuals who have harnessed the power of AI for good to solve real-world problems. HealthEquity won awards for "Innovative AI Products" in the categories of health and automation. "Our team identified a pain point for members, and they determined a way to fix it," said Bryan Rhodes, principal product manager at HealthEqu

      4/15/25 9:20:00 AM ET
      $HQY
      Business Services
      Consumer Discretionary
    • HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2025 Financial Results

      Highlights of the fiscal year include: Revenue of $1.20 billion, an increase of 20% compared to $999.6 million in FY24.Net income of $96.7 million, an increase of 74% compared to $55.7 million in FY24, with non-GAAP net income of $277.3 million, an increase of 42% compared to $195.5 million in FY24.Net income per diluted share of $1.09, an increase of 70% compared to $0.64 in FY24, with non-GAAP net income per diluted share of $3.12, an increase of 39% compared to $2.25 in FY24.Adjusted EBITDA of $471.8 million, an increase of 28% compared to $369.2 million in FY24.9.9 million HSAs, an increase of 14% compared to FY24.Total HSA Assets of $32.1 billion, an increase of 27% compared to F

      3/18/25 4:01:00 PM ET
      $HQY
      Business Services
      Consumer Discretionary

    $HQY
    SEC Filings

    See more
    • HealthEquity Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - HEALTHEQUITY, INC. (0001428336) (Filer)

      4/28/25 4:01:38 PM ET
      $HQY
      Business Services
      Consumer Discretionary
    • SEC Form 144 filed by HealthEquity Inc.

      144 - HEALTHEQUITY, INC. (0001428336) (Subject)

      4/10/25 4:55:06 PM ET
      $HQY
      Business Services
      Consumer Discretionary
    • SEC Form 144 filed by HealthEquity Inc.

      144 - HEALTHEQUITY, INC. (0001428336) (Subject)

      4/9/25 4:04:38 PM ET
      $HQY
      Business Services
      Consumer Discretionary

    $HQY
    Financials

    Live finance-specific insights

    See more
    • HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2025 Financial Results

      Highlights of the fiscal year include: Revenue of $1.20 billion, an increase of 20% compared to $999.6 million in FY24.Net income of $96.7 million, an increase of 74% compared to $55.7 million in FY24, with non-GAAP net income of $277.3 million, an increase of 42% compared to $195.5 million in FY24.Net income per diluted share of $1.09, an increase of 70% compared to $0.64 in FY24, with non-GAAP net income per diluted share of $3.12, an increase of 39% compared to $2.25 in FY24.Adjusted EBITDA of $471.8 million, an increase of 28% compared to $369.2 million in FY24.9.9 million HSAs, an increase of 14% compared to FY24.Total HSA Assets of $32.1 billion, an increase of 27% compared to F

      3/18/25 4:01:00 PM ET
      $HQY
      Business Services
      Consumer Discretionary
    • HealthEquity Reports Third Quarter Ended October 31, 2024 Financial Results

      Highlights of the third quarter include: Revenue of $300.4 million, an increase of 21% compared to $249.2 million in Q3 FY24.Net income of $5.7 million, compared to $14.7 million in Q3 FY24, with non-GAAP net income of $69.4 million, an increase of 33% compared to $52.2 million in Q3 FY24.Net income per diluted share of $0.06, compared to $0.17 in Q3 FY24, with non-GAAP net income per diluted share of $0.78, compared to $0.60 in Q3 FY24.Adjusted EBITDA of $118.2 million, an increase of 24% compared to $95.6 million in Q3 FY24.9.5 million HSAs, an increase of 15% compared to Q3 FY24.Total HSA Assets of $30.0 billion, an increase of 33% compared to Q3 FY24.16.5 million Total Accounts, inc

      12/9/24 4:01:00 PM ET
      $HQY
      Business Services
      Consumer Discretionary
    • HealthEquity Announces Retirement of CEO Jon Kessler; Scott Cutler Appointed Successor

      DRAPER, Utah, Nov. 12, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced that after leading the company for more than 15 years, Jon Kessler, President and Chief Executive Officer, has decided to retire effective January 6, 2025. Mr. Kessler will remain a director and act a special advisor to the Company through April 30, 2025. To succeed Mr. Kessler, the Company announced the appointment of Scott Cutler, who will join HealthEquity as President and CEO and as a director effective January 6, 2025. HealthEquity management will host a conference call for investors on Tues

      11/12/24 4:00:00 PM ET
      $BEP
      $HQY
      Electric Utilities: Central
      Utilities
      Business Services
      Consumer Discretionary

    $HQY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Selander Robert W exercised 12,500 shares at a strike of $28.68 and sold $446,513 worth of shares (5,750 units at $77.65), increasing direct ownership by 9% to 84,969 units (SEC Form 4)

      4 - HEALTHEQUITY, INC. (0001428336) (Issuer)

      4/11/25 12:53:52 PM ET
      $HQY
      Business Services
      Consumer Discretionary
    • FOUNDER AND VICE CHAIRMAN Neeleman Stephen covered exercise/tax liability with 9,019 shares, decreasing direct ownership by 7% to 113,642 units (SEC Form 4)

      4 - HEALTHEQUITY, INC. (0001428336) (Issuer)

      4/10/25 5:13:19 PM ET
      $HQY
      Business Services
      Consumer Discretionary
    • EVP, General Counsel Ladd Delano covered exercise/tax liability with 6,991 shares, decreasing direct ownership by 7% to 86,426 units (SEC Form 4)

      4 - HEALTHEQUITY, INC. (0001428336) (Issuer)

      4/10/25 5:05:24 PM ET
      $HQY
      Business Services
      Consumer Discretionary

    $HQY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • HealthEquity upgraded by Raymond James with a new price target

      Raymond James upgraded HealthEquity from Outperform to Strong Buy and set a new price target of $115.00 from $120.00 previously

      3/25/25 8:22:31 AM ET
      $HQY
      Business Services
      Consumer Discretionary
    • Mizuho initiated coverage on HealthEquity with a new price target

      Mizuho initiated coverage of HealthEquity with a rating of Outperform and set a new price target of $126.00

      12/4/24 7:41:08 AM ET
      $HQY
      Business Services
      Consumer Discretionary
    • Goldman initiated coverage on HealthEquity with a new price target

      Goldman initiated coverage of HealthEquity with a rating of Neutral and set a new price target of $108.00

      11/15/24 7:47:14 AM ET
      $HQY
      Business Services
      Consumer Discretionary

    $HQY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by HealthEquity Inc. (Amendment)

      SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)

      2/13/24 5:06:19 PM ET
      $HQY
      Business Services
      Consumer Discretionary
    • SEC Form SC 13G/A filed by HealthEquity Inc. (Amendment)

      SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)

      2/9/24 4:15:05 PM ET
      $HQY
      Business Services
      Consumer Discretionary
    • SEC Form SC 13G/A filed by HealthEquity Inc. (Amendment)

      SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)

      2/9/24 9:16:06 AM ET
      $HQY
      Business Services
      Consumer Discretionary